LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW)

CUSIP: G9845F117

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / *W EXP 03/15/202
Total 13F shares
4,920,424
Share change
-148,877
Total reported value
$402,582
Price per share
$0.09
Number of holders
21
Value change
-$9,791
Number of buys
1
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G9845F117?
CUSIP G9845F117 identifies LSBPW - LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) as of Q2 2024

As of 30 Jun 2024, LakeShore Biopharma Co., Ltd. - *W EXP 03/15/202 (LSBPW) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,920,424 shares. The largest 10 holders included LMR Partners LLP, Valliance Asset Management Ltd, BFAM Partners (Cayman) Ltd, JANE STREET GROUP, LLC, Finepoint Capital LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Bracebridge Capital, LLC, COWEN AND COMPANY, LLC, Calamos Advisors LLC, and Q Global Advisors, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.